Investor Relations

Press Releases

Date Title and Summary View
Jul 06, 2016

Appoints Former Senior J&J Executive responsible for leading launch of ORTHO EVRA®

Jun 23, 2016

Presentation Scheduled on Wednesday, July 13th, 2016 at 1:00 PM ET

Jun 16, 2016

Intellectual Property Portfolio Broadened for Its Proprietary Transdermal Delivery System

Jun 07, 2016

Presentation Scheduled on Tuesday, June 14th, 2016 at 2:50 PM Central Time

Jun 02, 2016

Presentation Scheduled on Friday, June 10th, 2016 at 10:30 AM Eastern Time

May 09, 2016
Cash Expected to Fund Operations through the End of 2017 Clinical Trial Expected to Complete in Fourth Quarter 2016 and Resubmission Planned for First Half 2017 PRINCETON, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical
Apr 15, 2016
PRINCETON, N.J. , April 15, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that Dr.
Mar 30, 2016

Presentation Scheduled on Wednesday, April 13, 2016 at 4:20 PM Eastern Time

Mar 09, 2016

Cash Expected to Fund Operations Through the End of 2017

Mar 03, 2016

Presentation Scheduled on Monday, March 14, 2016 at 7:30 AM Pacific Time